BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15094230)

  • 1. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.
    Brandsaeter B; Isoniemi H; Broomé U; Olausson M; Bäckman L; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Kirkegaard P; Friman S; Bjøro K
    J Hepatol; 2004 May; 40(5):815-22. PubMed ID: 15094230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
    Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation.
    Nashan B; Schlitt HJ; Tusch G; Oldhafer KJ; Ringe B; Wagner S; Pichlmayr R
    Hepatology; 1996 May; 23(5):1105-11. PubMed ID: 8621141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.
    Brandsaeter B; Broomé U; Isoniemi H; Friman S; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Olsson R; Olausson M; Kirkegaard P; Bjøro K
    Liver Transpl; 2003 Sep; 9(9):961-9. PubMed ID: 12942458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis and malignancy.
    Boberg KM; Lind GE
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):753-64. PubMed ID: 22117640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sclerosing cholangitis and biliary malignancy: a glimmer of hope?
    Chazouillères O
    J Hepatol; 2004 May; 40(5):857-9. PubMed ID: 15094236
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver transplantation in primary sclerosing cholangitis.
    Bjøro K; Brandsaeter B; Foss A; Schrumpf E
    Semin Liver Dis; 2006 Feb; 26(1):69-79. PubMed ID: 16496235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study.
    Fevery J; Henckaerts L; Van Oirbeek R; Vermeire S; Rutgeerts P; Nevens F; Van Steenbergen W
    Liver Int; 2012 Feb; 32(2):214-22. PubMed ID: 21745316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation.
    Prytz H; Keiding S; Björnsson E; Broomé U; Almer S; Castedal M; Munk OL;
    Hepatology; 2006 Dec; 44(6):1572-80. PubMed ID: 17133469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of primary sclerosing cholangitis in patients after liver transplantation.
    Ołdakowska-Jedynak U; Nowak M; Mucha K; Foroncewicz B; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Patkowski W; Górnicka B; Paczkowska A; Michałowicz B; Pilecki T; Pawlak J; Krawczyk M; Paczek L
    Transplant Proc; 2006; 38(1):240-3. PubMed ID: 16504713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver transplantation in patients with primary sclerosing cholangitis. Determining timing with reference to risk of malignancy].
    Nashan B; Tusch G; Schlitt HJ; Pichlmayr R
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():410-2. PubMed ID: 9101888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
    Weismüller TJ; Wedemeyer J; Kubicka S; Strassburg CP; Manns MP
    J Hepatol; 2008; 48 Suppl 1():S38-57. PubMed ID: 18304683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience.
    Morris-Stiff G; Bhati C; Olliff S; Hübscher S; Gunson B; Mayer D; Mirza D; Buckels J; Bramhall SR
    Dig Surg; 2008; 25(2):126-32. PubMed ID: 18446034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for sclerosing cholangitis.
    Narumi S; Roberts JP; Emond JC; Lake J; Ascher NL
    Hepatology; 1995 Aug; 22(2):451-7. PubMed ID: 7635412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
    Maheshwari A; Yoo HY; Thuluvath PJ
    Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
    Tischendorf JJ; Meier PN; Strassburg CP; Klempnauer J; Hecker H; Manns MP; Krüger M
    Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.